HAL (France)
open access
Sustained Therapeutic Efficacy of siPMP22-Squalene Nanoparticles in the C61 Mouse Model of CMT1A: A Preclinical Case Study for Clinical Translation
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Dually Acting Ligands Targeting Serotonin Receptors: Implications in CNS Disorders.#317977
- Clinic-to-Mechanism: Unraveling in-depth molecular dysfunctions caused by a GluN2B C-Terminal deletion in developmental and epileptic encephalopathies#330035
- Reversible, Light-Controlled Inhibition of STIM1-Mediated Calcium Signaling Using Photoswitchable ML-9 Derivatives in Jurkat-Lucia NFAT Reporter T Cells#411476
- Antisense-Oligonucleotide Gene Therapy for KCNC1-Related Developmental and Epileptic Encephalopathy#297899
- Integrative structural modelling reveals the human Mic60-Mic19 subcomplex as a diffusion barrier in mitochondria.#1107451
Record · ID 395467
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive